產(chǎn)品名稱 ABT 102
產(chǎn)品貨號(hào) Axon 1504 CAS [808756-71-0] MF C21H24N4OMW 348.44 Purity: 99% Optical purity: Optically pure Soluble in DMSO Description Potent and selective antagonist of transient receptor potential vanilloid 1 (TRPV1) receptors (IC50 values to be 5-7 nM) under clinical trials; TRVP1 receptor antagonism is a promising approach for pain management References Certificates Categories Extra info CS Surowy et al. ABT-102 Blocks Polymodal Activation of Transient Receptor Potential Vanilloid 1 Receptors in Vitro and Heat-Evoked Firing of Spinal Dorsal Horn Neurons in Vivo. JPET 2008, 326(3), 879-888.? ? P Honore et al. Repeated dosing of ABT-102, a potent and selective TRPV1 antagonist, enhances TRPV1-mediated analgesic activity in rodents, but attenuates antagonist-induced hyperthermia. Pain. 2009, 142(1-2), 27-35. Certificate of Analysis Material Safety Data Sheet CNS Pain & Inflammation TRPV1 Unclassified TRPV1 antagonist Chemical name (R)-1-(5-tert-Butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)urea Parent CAS No. [808756-71-0] Order Size Unit Price Stock 5 mg €90.00 In Stock
產(chǎn)品價(jià)格 現(xiàn)貨詢價(jià),電話:010-67529703
產(chǎn)品規(guī)格
產(chǎn)品品牌 axonmedchem
產(chǎn)品概述
產(chǎn)品詳情

ABT 102

Based on 14 reference(s) in Google Scholar 8 10 14

Axon 1504

CAS [808756-71-0]

MF C21H24N4O
MW 348.44

  • Purity: 99%
  • Optical purity: Optically pure
  • Soluble in DMSO

ABT 102

Description

Potent and selective antagonist of transient receptor potential vanilloid 1 (TRPV1) receptors (IC50 values to be 5-7 nM) under clinical trials; TRVP1 receptor antagonism is a promising approach for pain management
產(chǎn)品資料